Compare DE & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DE | MRK |
|---|---|---|
| Founded | 1837 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.9B | 317.8B |
| IPO Year | 1994 | 1995 |
| Metric | DE | MRK |
|---|---|---|
| Price | $588.72 | $135.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | ★ $632.56 | $125.59 |
| AVG Volume (30 Days) | 970.0K | ★ 5.8M |
| Earning Date | 05-21-2026 | 04-30-2026 |
| Dividend Yield | 1.16% | ★ 3.06% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | ★ 8.97 | N/A |
| Revenue | $45,684,000,000.00 | ★ $65,011,000,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | $9.39 | $5.41 |
| P/E Ratio | $66.88 | ★ N/A |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $433.00 | $77.58 |
| 52 Week High | $674.19 | $137.17 |
| Indicator | DE | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 43.99 | 66.24 |
| Support Level | $583.26 | $112.68 |
| Resistance Level | $596.39 | N/A |
| Average True Range (ATR) | 14.05 | 3.23 |
| MACD | -2.46 | 0.45 |
| Stochastic Oscillator | 10.23 | 78.02 |
Deere is the world's leading manufacturer of agricultural equipment and a major producer of construction machinery. The company is divided into four reporting segments: production & precision agriculture, or PPA, small agriculture & turf, or SAT, construction & forestry, or CF, and financial services, or FS, its captive finance subsidiary. The core PPA business is the largest contributor to sales and profits by far. Geographically, Deere sales are 60% US/Canada, 17% Europe, 14% Latin America, and 9% rest of the world. Deere goes to market through a robust dealer network that includes over 2,000 dealer locations in North America with reach into over 100 countries. John Deere Financial provides retail financing for machinery to its customers and wholesale financing for dealers.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).